Astellas prioritises ophthalmology with gene therapy acquisition
Astellas has announced that it will acquire Quethera and its gene therapy programmes for the treatment of glaucoma.
Archives for August 21, 2018
GE Healthcare opens bioprocessing ‘test bed’ for biotechs
The Testa BioProcess Innovation Center in Sweden will help academics, startups, and biopharmaceutical companies secure industrial proof-of-concepts quicker, and with less cost, says GE Healthcare.
Clinical trial boom boosts Cryoport revenues 59% in Q2 2018
Cryoport is supporting a record number of clinical trials driven by rapid growth in regenerative medicine – a space that will continue to grow and outpace the pharmaceutical industry, says CCO.